CHRONIX BIOMEDICAL INC — Form D/A
CHRONIX BIOMEDICAL INC of SAN JOSE, CA, a company, filed a Form D amendment with the SEC on 2014-04-09. The offering totals $14.5M, of which $3.4M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2014-04-09
- Form: D/A
- Accession: 0001129116-14-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $14.5M
- Amount sold: $3.4M
- Remaining: $11.1M
- Minimum investment: $5K
- Investors: 26
- Date of first sale: 2012-12-27
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-215150
Issuer
- Name: CHRONIX BIOMEDICAL INC
- CIK: 0001129116
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 5941 OPTICAL COURT, SAN JOSE, CA, 95138
- Phone: (408) 960-2307
Officers, directors & promoters (18)
| Name | Role | Location |
|---|
| William Mitchell | Director | Houston, TX |
| PAUL FREIMAN | Director | EMERYVILLE, CA |
| Michael Jerstad | Director | MINNETRISTA, MN |
| David MacKenzie | Director | London, X0 |
| William B Mitchell | Director | San Jose, CA |
| Michael B Jerstad | Director | Sioux Falls, SD |
| William B Boeger III | Director | San Jose, CA |
| David B MacKenzie | Director | Calgary, A0 |
| Ekkehard B Schuetz | Executive Officer | San Jose, CA |
| Robert B Leppo | Director | San Jose, CA |
| John DiPietro | Executive Officer | San Jose, CA |
| Howard B Urnovitz | Director | San Jose, CA |
| Howard B Urnovitz | Executive Officer | San Jose, CA |
| Paul B Freiman | Director | San Jose, CA |
| William Boeger III | Director | San Jose, CA |
| Howard Urnovitz | Director | San Jose, CA |
| Howard Urnovitz | Executive Officer | San Jose, CA |
| Robert Leppo | Director | Danville, CA |
Other filings by this issuer (8)
More